Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$66,211,127
+$7,464,326 QoQ
Shares Held
133,294
+1.3% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#150
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $556,047,667 across 189 Biotechnology names. VRTX ranks #2 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,211,127 | 133,294 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $58,746,801 | 131,560 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $61,030,869 | 134,619 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $88,437,794 | 225,814 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $80,241,066 | 180,236 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $81,864,280 | 168,855 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $67,709,172 | 168,138 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $97,775,162 | 210,233 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $135,760,997 | 289,642 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $106,785,252 | 255,461 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $102,055,742 | 250,819 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $105,692,441 | 303,941 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $166,964,754 | 474,453 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $168,199,487 | 533,848 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $196,510,746 | 680,486 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $208,156,673 | 718,922 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $198,838,349 | 705,626 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $195,428,687 | 748,855 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $145,046,897 | 660,505 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $110,789,020 | 610,778 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $87,462,656 | 433,778 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $62,983,827 | 293,098 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $116,125,652 | 491,350 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $1,484,958 | 5,457 | Shares | Defined | 2021-08-05 | |
| 2020-06-30 | $989,086 | 3,407 | Shares | Defined | 2021-08-05 | |
| 2020-03-31 | $599,871 | 2,521 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||